1Kurman RF, Carcangiu ML, Herrington CS, et al. WHO classicification of tumours of female reproductive organs [ M ]. Lyon : IARC Press,2014.
2Allison KH, Reed SD, Voigt LF, et al. Diagnosing endometrial hyperplasia: why is it so difficult to agree [ J ]. Am J Surg Pathol, 2008,32(5) :691-698. DOI:10. 1097/PAS. 0b013e318159a2a0.
3Kurman R J, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma [ J ]. Cancer, 1982, 49 ( 12 ) :2547 -2559.
4Longaere TA, Chung MH, Jensen DN, et al. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion[ J]. Am J Surg Pathol, 1995, 19 (4) :371-406.
5Randall TC, Kurman RJ. Pregestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 [ J ]. Obstet Gynecol, 1997, 90 ( 3 ) :434- 440.
6Truskinovsky AM, Lifschitz-Mercer B, Czemobilsky B. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge [J]. Int J Gynecol Pathol, 2014, 33 (2) : 107-113. DOI: 10. 1097/PGP. 0b013e3182a2945d,.
7Suh-Burgmanu E, Hung YY, Armstrong MA. The value of additional pathology comments indicating suspicion of adenocareiuoma among women diagnosed preoperatively with complex atypical endometrial hyperplasia [ J ]. Int J Gynecol Pathol, 2012, 31 ( 3 ): 222-226. DOI: 10. 1097/PGP. 0b013e31823et'Sb0.
8Joiner AK, Quick CM, Jeffus SK. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems [ J]. Int J Gynecol Pathol, 2015, 34( 1 ) :40-46. DOI: 10. 1097/ PGP. 0000000000000185.
9Buell-Gutbrod R, Cavallo A, Lee N, et al. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma[ J]. Int J Gynecol Pathol, 2015, 34 ( 1 ) : 65-73. DOI : 10. 1097/PGP. 0000000000000106.
